ES2100929T3 - Nuevos compuestos r106. - Google Patents

Nuevos compuestos r106.

Info

Publication number
ES2100929T3
ES2100929T3 ES91300438T ES91300438T ES2100929T3 ES 2100929 T3 ES2100929 T3 ES 2100929T3 ES 91300438 T ES91300438 T ES 91300438T ES 91300438 T ES91300438 T ES 91300438T ES 2100929 T3 ES2100929 T3 ES 2100929T3
Authority
ES
Spain
Prior art keywords
sub
beta
new
fmephe
homeval
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91300438T
Other languages
English (en)
Inventor
Fumiyo Haruna
Hideyo Yamaguchi
Teruya Nakamura
Katsuhisa Uchida
Kazutoh Takesako
Katsushige Ikai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takara Shuzo Co Ltd
Original Assignee
Takara Shuzo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Shuzo Co Ltd filed Critical Takara Shuzo Co Ltd
Application granted granted Critical
Publication of ES2100929T3 publication Critical patent/ES2100929T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

NUEVOS COMPUESTOS R106 REPRESENTADOS POR LA SIGUIENTE FORMULA GENERAL (I): EN DONDE: A SUB 1 ES PHE, O-FPHE, M-FPHE, O TUR; A SUB 2 ES MEPHE, O-FMEPHE, M-FMEPHE, METYR, SAR, MESER, O (BETA)-OXOMEPHE ; A SUB 3 ES PRO, 4HYP, O SPRO; A SUB 4 ES ALLO-LLE O NLE; A SUB 5 ES LEU O NVA; A SUB 6 ES (BETA)-HOMEVAL O SAR; EXCLUYENDO AQUELLOS EN DONDE A SUB 1 ES PHE Y A SUB 2 ES MEPHE Y A SUB 3 ES PRO Y A SUB 4 ES ALLO-LLE Y A SUB 5 ES LEU Y A SUB 6 ES (BETA)-HOMEVAL.
ES91300438T 1990-01-23 1991-01-21 Nuevos compuestos r106. Expired - Lifetime ES2100929T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014384A JP2639737B2 (ja) 1990-01-23 1990-01-23 新規ｒ１０６類化合物

Publications (1)

Publication Number Publication Date
ES2100929T3 true ES2100929T3 (es) 1997-07-01

Family

ID=11859560

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91300438T Expired - Lifetime ES2100929T3 (es) 1990-01-23 1991-01-21 Nuevos compuestos r106.

Country Status (5)

Country Link
US (1) US5200505A (es)
EP (1) EP0443719B1 (es)
JP (1) JP2639737B2 (es)
DE (1) DE69125963T2 (es)
ES (1) ES2100929T3 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69206007T2 (de) * 1991-02-19 1996-07-25 Takara Shuzo Co Fungizide für den Acker- und Gartenbau.
EP0547484A1 (en) * 1991-12-19 1993-06-23 Nippon Kayaku Kabushiki Kaisha Process for producing antibiotic R106-I
JP3480848B2 (ja) * 1992-06-19 2003-12-22 タカラバイオ株式会社 環状ペプチドの合成方法
JPH0672890A (ja) * 1992-06-26 1994-03-15 Nippon Kayaku Co Ltd オーレオバシジン類の乳化製剤
US6015689A (en) * 1993-05-24 2000-01-18 Takara Shuzo Co., Ltd. Regulation of aureobasidin sensitivity
DE69434662T2 (de) 1993-05-24 2006-12-07 Takara Bio Inc., Otsu Kodierung eines Gens für ein die Aureobasidinempfindlichkeit regulierendes Protein
US5698670A (en) * 1993-12-27 1997-12-16 Takara Shuzo Co., Ltd. Aureobasidins
US5739104A (en) * 1994-05-04 1998-04-14 Schering Corporation Anti-fungal agents
DE69504596T2 (de) 1994-06-29 1999-05-12 Takara Shuzo Co Chromosomaler Integrationsvektor
CA2205369A1 (en) * 1994-11-15 1996-05-23 Eli Lilly And Company Process for performing retro-aldol reaction
JPH08322575A (ja) * 1995-05-30 1996-12-10 Takara Shuzo Co Ltd プロモーター
US5629289A (en) * 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
ZA200406350B (en) * 2002-02-13 2006-11-29 Teva Gyogyszergyar Reszveny Tarsasag Method for extracting a macrolide from biomatter
US7452692B2 (en) * 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
TW200504079A (en) * 2003-03-31 2005-02-01 Biogal Gyogyszergyar Crystallization and purification of macrolides
US20060169199A1 (en) * 2003-03-31 2006-08-03 Vilmos Keri Crystallization and purification of macrolides
ATE378345T1 (de) * 2003-07-24 2007-11-15 Teva Gyogyszergyar Zartkoeruee Verfahren zur aufreinigung von makroliden
JP3916166B2 (ja) * 2004-09-27 2007-05-16 学校法人慶應義塾 化合物ライブラリーの作製方法、並びに、スクリーニング方法
US8940265B2 (en) * 2009-02-17 2015-01-27 Mcalister Technologies, Llc Sustainable economic development through integrated production of renewable energy, materials resources, and nutrient regimes
MX2007005868A (es) * 2004-12-22 2007-07-04 Teva Gyogyszergyar Zartkoeruen Mukoedo Reszvenytarsasag Metodo de purificar tacrolimus.
WO2007025181A2 (en) * 2005-08-26 2007-03-01 Aureogen Biosciences Aureobasidin a synthetase
WO2020018888A1 (en) 2018-07-20 2020-01-23 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use
CN112779167B (zh) * 2021-01-11 2022-06-21 浙江珲达生物科技有限公司 一种Aureobasidin A高产菌株及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342751A (en) * 1981-03-09 1982-08-03 Eli Lilly And Company Majusculamide C
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
US5057493A (en) * 1988-07-19 1991-10-15 Takara Shuzo Co., Ltd. Novel antibiotics r106

Also Published As

Publication number Publication date
DE69125963T2 (de) 1997-12-18
US5200505A (en) 1993-04-06
JPH03220199A (ja) 1991-09-27
EP0443719A1 (en) 1991-08-28
JP2639737B2 (ja) 1997-08-13
DE69125963D1 (de) 1997-06-12
EP0443719B1 (en) 1997-05-07

Similar Documents

Publication Publication Date Title
ES2100929T3 (es) Nuevos compuestos r106.
FI910286A0 (fi) Analoger av humant insulin och preparat innehaollande dessa.
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
DE68908302T2 (de) Endstück für zahnmedizinische Spritzdüse.
DK0607389T3 (da) Bearbejdelige, cementbaserede sammensætninger
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
DK0956033T3 (da) Totalsyntese af amino-Hip-analogen af didemnin A
SE9101838D0 (sv) Novel peptides and their use
AR015945A1 (es) Composiciones de spray para el cabello autofobicas
DE69111663T2 (de) PH-unempfindliches Antikogationsmittel für Tintenstrahlschreiber.
ATE77628T1 (de) Peptidverbindungen.
DK455088D0 (da) Syntetiske receptoranaloger
DE58907940D1 (de) Neue Stoffzusammensetzungen enthaltend Molybdändisulfid.
ES2067730T3 (es) Nueva colagenasa de 92 kda de tipo iv.
OA09192A (en) "Stabilized sulfur dissolving compositions".
JPS52106836A (en) N-trichloroacetyl-n#-chlorobenzoylhydrazine derivatives and germicide s for agriculture and horticulture containing thereof
IT9047924A0 (it) Composizione per l'igiene orale.
JPS5312958A (en) Mercapto group-containing silicone rubber composition
ES2121209T3 (es) Punta de corazon de cruzamiento.
IT8819731A0 (it) Composizioni farmaceutiche contenenti timosina alfa 1.
JPS5225767A (en) Preparation of tyrosinated c-peptides and radioactive iodinated deriva tives thereof
DE68909120T2 (de) Schutzvorrichtung für Pflanzen gegen Raubtiere.
JPS535124A (en) Organoxilicon composition
DE68900131D1 (de) Biozide 4,5-dichlor-1,2-dithiol-3-on-zusammensetzung.
ITMI911909A1 (it) Tessuto elasticizzato sagomabile per l'applicazione al corpo di animali sottoposti a biotosatura.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 443719

Country of ref document: ES